Thyroid lymphoma: Beyond antigen stimulation

Leukemia Research

Volumn 33, Issue 5, 2009, Pages 607-609

  Rossi, Davide ^a  

^a BRMA   (Italy)

Author keywords

Aberrant somatic hypermutation; Lymphoma; Thyroid

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

CARCINOGENESIS; CHROMOSOME TRANSLOCATION; EDITORIAL; HUMAN; IMMUNOSTIMULATION; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SOMATIC HYPERMUTATION; THYROID NONHODGKIN LYMPHOMA;

ANTIGENS, NEOPLASM; HUMANS; LYMPHOMA, NON-HODGKIN; THYROID NEOPLASMS;

EID: 61449165673     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.11.015     Document Type: Editorial

References (30)

1. Freeman C., Berg J., and Culter S. Occurrence and prognosis of extranodal lymphoma. Pathologic project 1982 National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a Working Formulation for a clinical usage. Cancer 49 (1977) 2112-2135
2. Tsang R.W., Gospodarowicz M.K., Sutcliffe S.B., Sturgeon J.F., Panzarella T., and Patterson B.J. Non-Hodgkin's lymphoma of the thyroid gland: prognostic factors and treatment outcome. The Princess Margaret Hospital Lymphoma Group. Int J Radiat Oncol Biol Phys 27 (1993) 599-604
3. Derringer G.A., Thompson L.D., Frommelt R.A., Bijwaard K.E., Heffess C.S., and Abbondanzo S.L. Malignant lymphoma of the thyroid gland: a clinicopathologic study of 108 cases. Am J Surg Pathol 24 (2000) 623-639
4. Ha C.S., Shadle K.M., Medeiros L.J., Wilder R.B., Hess M.A., Cabanillas F., et al. Localized non-Hodgkin lymphoma involving the thyroid gland. Cancer 91 (2001) 629-635
5. Harrington K.J., Michalaki V.J., Vini L., Nutting C.M., Syrigos K.N., A'hern R., et al. Management of non-Hodgkin's lymphoma of the thyroid: the Royal Marsden Hospital experience. Br J Radiol 78 (2005) 405-410
6. Niitsu N., Okamoto M., Nakamura N., Nakamine H., Bessho M., and Hirano M. Clinicopathologic correlations of stage IE/IIE primary thyroid diffuse large B-cell lymphoma. Ann Oncol 18 (2007) 1203-1208
7. Isaacson P.G., Androulakis-Papachristou A., Diss T.C., Pan L., and Wright D.H. Follicular colonization in thyroid lymphoma. Am J Pathol 141 (1992) 43-52
8. Bacon CM, Diss TC, Ye H, Liu H, Goatly A, Hamoudi R, Wotherspoon A, Gascoyne RD, Dogan A, Du MQ, Isaacson PG. Follicular lymphoma of the thyroid gland. Am J Surg Pathol; in press, doi:10.1037/PAS.06.013e31817d7470.
9. Holm L.E., Blomgren H., and Löwhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 312 (1985) 601-604
10. Saxena A., Alport E.C., Moshynska O., Kanthan R., and Boctor M.A. Clonal B cell populations in a minority of patients with Hashimoto's thyroiditis. J Clin Pathol 57 (2004) 1258-1263
11. Moshynska O.V., and Saxena A. Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol 61 (2008) 438-444
12. Sato Y., Nakamura N., Nakamura S., Sakugawa S., Ichimura K., Tanaka T., et al. Deviated VH4 immunoglobulin gene usage is found among thyroid mucosa-associated lymphoid tissue lymphomas, similar to the usage at other sites, but is not found in thyroid diffuse large B-cell lymphomas. Mod Pathol 19 (2006) 1578-1584
13. Streubel B., Vinatzer U., Lamprecht A., Raderer M., and Chott A. t(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 19 (2005) 652-658
14. Ott G., Katzenberger T., Greiner A., Kalla J., Rosenwald A., Heinrich U., et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res 57 (1997) 3944-3948
15. Remstein E.D., James C.D., and Kurtin P.J. Incidence and subtype specificity of API2-MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas. Am J Pathol 156 (2000) 1183-1188
16. Streubel B., Lamprecht A., Dierlamm J., Cerroni L., Stolte M., Ott G., et al. t(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 101 (2003) 2335-2339
17. Ye H., Liu H., Attygalle A., Wotherspoon A.C., Nicholson A.G., Charlotte F., et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 102 (2003) 1012-1018
18. Niitsu N., Okamoto M., Yoshino T., Nakamine H., Nakamura N., Bessho M., et al. t(8;14)(q24;q32) in two patients with CD10-negative primary thyroid diffuse large B-cell lymphoma. Leuk Res 31 (2007) 707-711
19. Du M., Peng H., Singh N., Isaacson P.G., and Pan L. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 86 (1995) 4587-4593
20. Klein U., and Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8 (2008) 22-33
21. Takakuwa T., Dong Z., Takayama H., Matsuzuka F., Nagata S., and Aozasa K. Frequent mutations of Fas gene in thyroid lymphoma. Cancer Res 61 (2001) 1382-1385
22. Pasqualucci L., Neumeister P., Goossens T., Nanjangud G., Chaganti R.S., Küppers R., et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 412 (2001) 341-346
23. Gaidano G., Pasqualucci L., Capello D., Berra E., Deambrogi C., Rossi D., et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 102 (2003) 1833-1841
24. Montesinos-Rongen M., Van Roost D., Schaller C., Wiestler O.D., and Deckert M. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood 103 (2004) 1869-1875
25. Cerri M., Capello D., Muti G., Rambaldi A., Paulli M., Gloghini A., et al. Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders. Br J Haematol 127 (2004) 362-364
26. Rossi D., Cerri M., Capello D., Deambrogi C., Berra E., Franceschetti S., et al. Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. Leukemia 19 (2005) 2363-2366
27. Dijkman R., Tensen C.P., Buettner M., Niedobitek G., Willemze R., and Vermeer M.H. Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID. Blood 107 (2006) 4926-4929
28. Liso A., Capello D., Marafioti T., Tiacci E., Cerri M., Distler V., et al. Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood 108 (2006) 1013-1020
29. Rossi D., Berra E., Cerri M., Deambrogi C., Barbieri C., Franceschetti S., et al. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica 91 (2006) 1405-1409
30. Deutsch A.J., Aigelsreiter A., Staber P.B., Beham A., Linkesch W., Guelly C., et al. MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation. Blood 109 (2007) 3500-3504